跳至主要内容
临床试验/SLCTR/2018/015
SLCTR/2018/015已完成4 期

The Effect of granulocyte colony-stimulating factor and erythropoietin on survival in patients with Acute-on-Chronic Liver Failure

Dr. Md. Nazmul Haque0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age:>18 years
  • Sex: both sexes
  • Bilirubin > 5 mg/dl
  • Coagulopathy (international normalized ratio > 1.5)
  • Complicated by clinical ascites and/or encephalopathy within 4 weeks
  • Patient with previously diagnosed or undiagnosed chronic liver disease
  • Acute insult caused by reactivation of HBV, HBV Flare, HEV,HAV or any aetiology

排除标准

  • Age <18 years
  • Decompensated Cirrhosis
  • Coexistent hepatocellular carcinoma (HCC)
  • Patients on immune-modulator or cytotoxic/immunosuppressive therapy
  • Co morbidity like heart failure, any malignancy and uncontrolled diabetic patients
  • Any previous known hypersensitivity to G-CSF and EPO
  • Patients unwilling to take part in the study

研究者

发起方
Dr. Md. Nazmul Haque

相似试验